• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clearance of Magnesium in Peritoneal Dialysis Patients: A Single-Center Study.腹膜透析患者镁清除率:单中心研究。
Blood Purif. 2019;47 Suppl 1(Suppl 1):1-7. doi: 10.1159/000496217. Epub 2019 Jan 30.
2
Drain volume required for a target peritoneal clearance: formulae based on peritoneal transport type and body size.目标腹膜清除率所需的引流液量:基于腹膜转运类型和体型的公式
ASAIO J. 1998 Nov-Dec;44(6):828-34.
3
Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.持续非卧床腹膜透析患者的镁稳态:透析液镁浓度的作用
Artif Organs. 2003 Sep;27(9):853-7. doi: 10.1046/j.1525-1594.2003.07193.x.
4
Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.使用低镁腹膜透析液的持续性非卧床腹膜透析(CAPD)患者血清甲状旁腺激素与镁水平之间的关系。
Korean J Intern Med. 2002 Jun;17(2):114-21. doi: 10.3904/kjim.2002.17.2.114.
5
Body surface area limitations in achieving adequate therapy in peritoneal dialysis patients.腹膜透析患者在实现充分治疗方面的体表面积限制。
Perit Dial Int. 1996 Nov-Dec;16(6):617-22.
6
Measurement of serum ionized magnesium in CAPD patients.持续性非卧床腹膜透析患者血清离子镁的测定
Perit Dial Int. 1997 Jul-Aug;17(4):347-52.
7
Clinical performance measures: the changing status of peritoneal dialysis.临床性能指标:腹膜透析的变化状况
Kidney Int. 2001 Dec;60(6):2377-84. doi: 10.1046/j.1523-1755.2001.00060.x.
8
Serum Magnesium Abnormality and Influencing Factors of Serum Magnesium Level in Peritoneal Dialysis Patients: A Single-Center Study in Northern China.血清镁异常及中国北方单中心腹膜透析患者血清镁水平的影响因素研究。
Blood Purif. 2018;45(1-3):110-117. doi: 10.1159/000485315. Epub 2017 Dec 14.
9
Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis.腹膜透析中无残余肾功能时的充分性与营养状况
Adv Perit Dial. 2001;17:230-4.
10
Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis.接受短留腹透治疗的高膜转运者的透析充分性指标
Adv Perit Dial. 1995;11:110-3.

引用本文的文献

1
A Case of Laxative-Induced Severe Hypermagnesemia in a Peritoneal Dialysis Patient.一名腹膜透析患者因服用泻药导致严重高镁血症的病例。
Cureus. 2025 Apr 8;17(4):e81923. doi: 10.7759/cureus.81923. eCollection 2025 Apr.
2
Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.新型冠状病毒肺炎的体外血液净化治疗选择:免疫吸附的作用
Transfus Apher Sci. 2020 Aug;59(4):102855. doi: 10.1016/j.transci.2020.102855. Epub 2020 Jun 25.

本文引用的文献

1
Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients.低镁血症与腹膜透析患者死亡率增加有关。
PLoS One. 2016 Mar 29;11(3):e0152488. doi: 10.1371/journal.pone.0152488. eCollection 2016.
2
Serum Magnesium and Sudden Death in European Hemodialysis Patients.欧洲血液透析患者的血清镁与猝死
PLoS One. 2015 Nov 23;10(11):e0143104. doi: 10.1371/journal.pone.0143104. eCollection 2015.
3
Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients.慢性肾脏病 3 期和 4 期及透析患者的镁
Clin Kidney J. 2012 Feb;5(Suppl 1):i39-i51. doi: 10.1093/ndtplus/sfr166.
4
Magnesium and Dialysis: The Neglected Cation.镁与透析:被忽视的阳离子。
Am J Kidney Dis. 2015 Sep;66(3):523-31. doi: 10.1053/j.ajkd.2015.01.029. Epub 2015 Apr 9.
5
HYPERMAGNESEMIA IN RENAL FAILURE. ETIOLOGY AND TOXIC MANIFESTATIONS.肾衰竭中的高镁血症。病因及中毒表现。
Ann Intern Med. 1964 Jul;61:73-88. doi: 10.7326/0003-4819-61-1-73.
6
Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.持续非卧床腹膜透析患者的镁稳态:透析液镁浓度的作用
Artif Organs. 2003 Sep;27(9):853-7. doi: 10.1046/j.1525-1594.2003.07193.x.
7
Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析中的矿物质、维生素D和甲状旁腺激素
Kidney Int. 1982 Jun;21(6):862-7. doi: 10.1038/ki.1982.110.

腹膜透析患者镁清除率:单中心研究。

Clearance of Magnesium in Peritoneal Dialysis Patients: A Single-Center Study.

机构信息

Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China,

出版信息

Blood Purif. 2019;47 Suppl 1(Suppl 1):1-7. doi: 10.1159/000496217. Epub 2019 Jan 30.

DOI:10.1159/000496217
PMID:30699418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6518854/
Abstract

OBJECTIVE

This retrospective study aimed to investigate the clearance of magnesium (Mg) in peritoneal dialysis (PD) patients and its influencing factors.

METHODS

The demographic information, clinical characteristics and laboratory data of the patients were collected. According to the corrected serum Mg (cS-Mg) concentration, patients were divided into 3 groups including hypomagnesemia (Mg2+ < 0.77 mmol/L, group A), normal serum Mg concentration (0.77 mmol/L ≤ Mg2+ ≤1.03 mmol/L, group B), and hypermagnesemia (Mg2+ > 1.03 mmo/L, group C).

RESULTS

One hundred and fifteen patients were enrolled, and their mean 24 h-peritoneal Mg clearance was 39.75 ± 17.42 mg. The mean normalized peritoneal Mg clearance rate was 1.82 ± 0.82 L/day/1.73 m2. Twenty-four-hour peritoneal Mg clearance of group A was significantly lower than that of group C (p < 0.05). Bivariate correlation analysis showed that cS-Mg was positively correlated with peritoneal dialysate Mg concentration (p < 0.01). cS-Mg was negatively correlated with the normalized peritoneal Mg clearance rate (p < 0.05). The normalized peritoneal Mg clearance rate was positively correlated with prealbumin (p < 0.05), daily peritoneal protein loss (p < 0.01) and the normalized PD-creatinine clearance rate (p < 0.01). The normalized peritoneal Mg clearance rate was also negatively correlated with the normalized renal-creatinine clearance rate (p < 0.01). Furthermore, cS-Mg of patients with continuous ambulatory PD (CAPD) was significantly lower than that of patients with daytime ambulatory PD (DAPD, p < 0.01). The normalized peritoneal Mg clearance rate of patients with CAPD was significantly higher than that of patients with DAPD (p < 0.01). Moreover, among the patients with different peritoneal transport characteristics of peritoneal equilibration test, the normalized peritoneal Mg clearance rate of high average transport patients was significantly higher than that in those with low transport, low average transport and high transport (p < 0.05).

CONCLUSIONS

Serum Mg could be partly cleared by PD. The peritoneal Mg clearance was positively related with serum Mg concentration, which was concentration-dependent. Peritoneal Mg clearance was negatively correlated with the residual renal function, while being positively correlated with the nutritional status and daily peritoneal protein loss. Peritoneal Mg clearance was higher in patients with high transport characteristics or CAPD.

摘要

目的

本回顾性研究旨在探讨腹膜透析(PD)患者镁(Mg)的清除率及其影响因素。

方法

收集患者的人口统计学信息、临床特征和实验室数据。根据校正后血清镁(cS-Mg)浓度,患者被分为 3 组,包括低镁血症(Mg2+<0.77mmol/L,组 A)、正常血清镁浓度(0.77mmol/L≤Mg2+≤1.03mmol/L,组 B)和高镁血症(Mg2+>1.03mmol/L,组 C)。

结果

共纳入 115 例患者,其 24 小时腹膜 Mg 清除率的平均值为 39.75±17.42mg。归一化腹膜 Mg 清除率为 1.82±0.82L/天/1.73m2。组 A 的 24 小时腹膜 Mg 清除率明显低于组 C(p<0.05)。双变量相关分析表明,cS-Mg 与腹膜透析液 Mg 浓度呈正相关(p<0.01)。cS-Mg 与归一化腹膜 Mg 清除率呈负相关(p<0.05)。归一化腹膜 Mg 清除率与前白蛋白(p<0.05)、每日腹膜蛋白丢失(p<0.01)和归一化 PD-肌酐清除率(p<0.01)呈正相关。归一化腹膜 Mg 清除率与归一化肾肌酐清除率呈负相关(p<0.01)。此外,持续非卧床腹膜透析(CAPD)患者的 cS-Mg 明显低于日间非卧床腹膜透析(DAPD,p<0.01)。CAPD 患者的归一化腹膜 Mg 清除率明显高于 DAPD 患者(p<0.01)。此外,在腹膜平衡试验不同腹膜转运特征的患者中,高平均转运患者的归一化腹膜 Mg 清除率明显高于低转运、低平均转运和高转运患者(p<0.05)。

结论

血清 Mg 可部分通过 PD 清除。腹膜 Mg 清除率与血清 Mg 浓度呈正相关,呈浓度依赖性。腹膜 Mg 清除率与残余肾功能呈负相关,而与营养状况和每日腹膜蛋白丢失呈正相关。具有高转运特征或 CAPD 的患者腹膜 Mg 清除率较高。